Search Results - "Mazzu, Arthur L."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Assessment of the Effects of Renal Impairment on the Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat After a Single Intravenous Dose by Lettieri, John T., Scheerans, Christian, Blunck, Martin, Mazzu, Arthur L., Frey, Reiner, Mück, Wolfgang, Sundaresan, Pavur R.

    Published in Journal of clinical pharmacology (01-08-2012)
    “…This open-label, parallel-group, single-dose study assessed the safety and pharmacokinetics of cinaciguat, a novel soluble guanylate cyclase activator in…”
    Get full text
    Journal Article
  2. 2

    Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin by Mazzu, Arthur L., Lasseter, Kenneth C., Shamblen, E. Cooper, Agarwal, Vipin, Lettieri, John, Sundaresen, Pavur

    Published in Clinical pharmacology and therapeutics (01-10-2000)
    “…Background 3‐Hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors (statins) are metabolized by distinct pathways that may alter the extent of drug‐drug…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Comparative effects of nitrendipine and hydrochlorothiazide on calciotropic hormones and bone density in hypertensive patients by Giles, T D, Sander, G E, Roffidal, L E, Quiroz, A C, Mazzu, A L

    Published in American journal of hypertension (01-12-1992)
    “…The effects of the calcium antagonist nitrendipine and the diuretic hydrochlorothiazide on plasma calciotropic hormone concentrations and lumbar bone density…”
    Get more information
    Journal Article
  5. 5

    Lack of mutual pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin in healthy normocholesterolemic volunteers by Weber, Paul, Lettieri, John T., Kaiser, Lee, Mazzu, Arthur L.

    Published in Clinical therapeutics (01-09-1999)
    “…The potential mutual interaction between cerivastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, and digoxin was assessed in this nonmasked,…”
    Get full text
    Journal Article
  6. 6

    Multiple dose pharmacokinetics of four different doses of nisoldipine in hypertensive patients by Chandler, M H, Clifton, G D, Lettieri, J T, Mazzu, A L, Allington, D R, Thieneman, A C, Foster, T S, Harrison, M R

    Published in Journal of clinical pharmacology (01-06-1992)
    “…This randomized double-blind parallel group study characterized the pharmacokinetics of the calcium channel antagonist, nisoldipine (core-coat tablets),…”
    Get more information
    Journal Article
  7. 7